Clinical Trial Update: Effects of TNF-alpha Antagonism (Etanercept) in Patients With the Metabolic Syndrome and Psoriasis [NA]

View source ↗

Summary

This terminated clinical trial evaluated the effects of the TNF-alpha antagonist etanercept in patients with psoriasis and metabolic syndrome, with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia
• Hypertension
• Metabolic Syndrome
• Obesity
• Psoriasis

Drugs mentioned

• ENBREL (etanercept)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Psoriasis, Metabolic Syndrome | NA | Status: TERMINATED | Results posted: 2016-05-16